Found 136 articles for: "skin of color"
Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review
April 2026 | Volume 25 | Issue 4 | Original Article | 316 | Copyright © April 2026
Background: Janus kinase (JAK) inhibitors represent promising therapies for dermatologic conditions, including psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), s...
Read MoreAn Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
April 2026 | Volume 25 | Issue 4 | Original Article | 330 | Copyright © April 2026
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in d...
Read MoreDelays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study
April 2026 | Volume 25 | Issue 4 | Features | 391 | Copyright © April 2026
Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome
February 2026 | Volume 25 | Issue 2 | Original Article | 159 | Copyright © February 2026
Background: Racial disparities in clinical trial enrollment can limit the generalizability of therapeutic data, which is particularly damaging for conditions that disproportionat...
Read MoreUnveiling Artificial Intelligence's Diagnostic Power and Challenges in Dermatology for Skin of Color: A Review
January 2026 | Volume 25 | Issue 1 | Editorials | e22 | Copyright © January 2026
Halo Seborrheic Keratosis in a Patient of Color With Vitiligo
January 2026 | Volume 25 | Issue 1 | Case Reports | 95 | Copyright © January 2026
A 73-year-old woman with Fitzpatrick skin type V presented with a long-standing brownish-black, three-tone macule on the right anterior thigh that developed a sharply demarcated depigmented halo....
Read MoreDisparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024
December 2025 | Volume 24 | Issue 12 | Original Article | 1203 | Copyright © December 2025
Background: There is a notable lack of diversity in dermatologic studies, even concerning conditions that are known to have a higher prevalence in the skin of color (SOC) populat...
Read MoreColorimetric Scale for Skin of Color to Classify Individuals With Darker Skin to Promote Awareness and Improve Diagnosis and Patient Outcomes
November 2025 | Volume 24 | Issue 11 | Editorials | e66 | Copyright © November 2025
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage
July 2025 | Volume 24 | Issue 7 | | 662 | Copyright © July 2025
Visible light (400-700nm) comprises 45% of the sunlight spectrum and can induce both immediate and persistent skin darkening, as well as worsen dyschromia, especially in the skin of color populat...
Read MoreLarge Multiethnic Comparison Benchmark of the Fitzpatrick and Monk Skin Tone Scales
July 2025 | Volume 24 | Issue 7 | Editorials | e46 | Copyright © July 2025
The Impact of Increasing Skin of Color Representation in the Pre-Clerkship Dermatology Curriculum
July 2025 | Volume 24 | Issue 7 | Editorials | e50 | Copyright © July 2025
Multidisciplinary Impact and Ethical Response to Skin Bleaching and Colorism
July 2025 | Volume 24 | Issue 7 | | e48 | Copyright © July 2025
Pincer Nail Deformity in an African American Patient Corrected by Fractionated Carbon Dioxide Laser
July 2025 | Volume 24 | Issue 7 | | 700 | Copyright © July 2025
Pincer nail deformity is a painful nail condition characterized by excessive transverse curvature of the nail plate that pinches the surrounding tissue. Treatments such as nail braces and surgical int...
Read MoreThiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation
June 2025 | Volume 24 | Issue 6 | Original Article | 608 | Copyright © June 2025
Cutaneous hyperpigmentation, including melasma, solar lentigines, and post-inflammatory hyperpigmentation (PIH), results in a significant impact on patients’ quality of life. Unfortunately,...
Read MoreTop Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color
April 2025 | Volume 24 | Issue 4 | Original Article | 403 | Copyright © April 2025
Background: By 2044, people with skin of color (SOC) in the United States are projected to become the majority of the population, yet research and practice gaps remain regarding ...
Read MoreError: 429: HTTP/2 429Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials
April 2025 | Volume 24 | Issue 4 | | 360 | Copyright © April 2025
Read MoreConcurrent Lichen Planopilaris and Female Androgenic Alopecia in Skin of Color: A Case Series
March 2025 | Volume 24 | Issue 3 | Case Reports | 320 | Copyright © March 2025
Background: Trichoscopy findings can differ in the skin of color requiring a dedicated approach with adequate examination in order to ensure proper diagnosis and treatment. This ...
Read MoreInsights Into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study
February 2025 | Volume 24 | Issue 2 | Features | 212 | Copyright © February 2025
Hypertrophic scars and keloids represent abnormal wound healing, manifesting as raised scars confined to or extending beyond the wound margin, respectively. Understanding the risk factors associated w...
Read MoreCo-occurring Melanoma in an Active Area of Vitiligo in Skin of Color
February 2025 | Volume 24 | Issue 2 | Case Reports | 205 | Copyright © February 2025
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patie...
Read MoreKeloidal Morphea: A Unique Variant of Morphea Presenting in a Black Female
February 2025 | Volume 24 | Issue 2 | Case Reports | 203 | Copyright © February 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
